Award Announced in Partnership with Chordoma Foundation

The Mark Foundation has partnered with the Chordoma Foundation to sponsor a Therapeutic Innovation Award aimed at accelerating the development of drug therapies targeting brachyury, a transcription factor that plays a key role in chordoma and other cancers. Letters of Intent for this one-year, $150K award are due Friday, April 6th.  Follow this link for details.